HomeCompareBOBP vs JNJ

BOBP vs JNJ: Dividend Comparison 2026

BOBP yields 3.38% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BOBP wins by $4.9K in total portfolio value
10 years
BOBP
BOBP
● Live price
3.38%
Share price
$25.32
Annual div
$0.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$420.62
Full BOBP calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BOBP vs JNJ

📍 BOBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOBPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOBP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOBP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOBP
Annual income on $10K today (after 15% tax)
$287.58/yr
After 10yr DRIP, annual income (after tax)
$357.53/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $346.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOBP + JNJ for your $10,000?

BOBP: 50%JNJ: 50%
100% JNJ50/50100% BOBP
Portfolio after 10yr
$22.4K
Annual income
$624.20/yr
Blended yield
2.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BOBP
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOBP buys
0
JNJ buys
0
No recent congressional trades found for BOBP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOBPJNJ
Forward yield3.38%3.36%
Annual dividend / share$0.86$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.9K$20.0K
Annual income after 10y$420.62$827.78
Total dividends collected$3.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BOBP vs JNJ ($10,000, DRIP)

YearBOBP PortfolioBOBP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,038$338.33$10,676$355.77+$362.00BOBP
2$12,160$349.03$11,407$389.39+$753.00BOBP
3$13,371$359.35$12,198$426.53+$1.2KBOBP
4$14,676$369.27$13,056$467.62+$1.6KBOBP
5$16,082$378.80$13,987$513.12+$2.1KBOBP
6$17,596$387.94$14,998$563.56+$2.6KBOBP
7$19,224$396.69$16,098$619.52+$3.1KBOBP
8$20,975$405.04$17,295$681.69+$3.7KBOBP
9$22,856$413.02$18,599$750.82+$4.3KBOBP
10$24,876$420.62$20,022$827.78+$4.9KBOBP

BOBP vs JNJ: Complete Analysis 2026

BOBPStock

BOBP invests in US large-cap securities identified to have favorable near- to medium-term capital appreciation potential based on equity skewness, a measure of how returns are likely to be higher or lower than average. Positive skewness suggests more frequent small losses and fewer but larger gains, while negative skewness implies more frequent small gains and fewer but larger losses. The index calculates equity skewness using a moving average and considers the correlation of each securitys return to its universe-wide average. If the universe-wide skewness is positive, the fund selects stocks with positive skewness. If the universe-wide skewness is negative, it favors stocks with less negative skewness. Based on these conditions, the fund selects and equally weights the top 50 stocks. The methodology aims to filter market noise and short-term volatility. The fund allocates 10-20% to cash and cash equivalents according to proprietary indicators. The index is rebalanced bi-weekly.

Full BOBP Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BOBP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOBP vs SCHDBOBP vs JEPIBOBP vs OBOBP vs KOBOBP vs MAINBOBP vs ABBVBOBP vs MRKBOBP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.